We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
The 2023-2028 Outlook for Schizophrenia Treatments in the United States
Price data last checked 91 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Product Specifications
- Format
- paperback
- ASIN
- B0BLPZBN7G
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 26 October 2022
- Listed Since
- 10 November 2022
Similar Products You Might Like
98% match
The 2023-2028 Outlook for Schizophrenia Drugs in the United States
£520.00
25 Jan 2026
98% match
The 2023-2028 Outlook for Antipsychotic Drugs for Schizophrenia in the United States
£520.00
10 Dec 2025
97% match
The 2023-2028 Outlook for Anxiety Disorder Treatments in the United States
£520.00
24 Jan 2026
97% match
The 2023-2028 Outlook for Anxiety Disorders and Depression Treatments in the United States
£520.00
25 Jan 2026
97% match
The 2023-2028 Outlook for Anxiety Disorder Therapeutics in the United States
£520.00
25 Jan 2026
97% match
The 2023-2028 Outlook for Autism Spectrum Disorder Therapeutics in the United States
£520.00
12 Jan 2026
97% match
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Amyloidosis Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
£520.00
15 Jan 2026
96% match
The 2023-2028 Outlook for Stress Management Treatments in the United States
£520.00
31 Jan 2026
96% match
The 2023-2028 Outlook for Pulmonary Fibrosis Treatments in the United States
£520.00
13 Jan 2026
96% match
The 2023-2028 Outlook for Autism Therapies in the United States
£520.00
12 Jan 2026
96% match
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
£520.00
05 Feb 2026
96% match
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
£520.00
14 Jan 2026
96% match
The 2023-2028 Outlook for Anti-Inflammatory Scleroderma Drugs in the United States
£520.00
29 Jan 2026
96% match
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
£520.00
07 Feb 2026
96% match
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
£520.00
31 Jan 2026
96% match
The 2023-2028 Outlook for Atopic Dermatitis Treatments in the United States
£520.00
23 Jan 2026
96% match
The 2023-2028 Outlook for Anxiety Disorders and Depression in the United States
£520.00
22 Jan 2026
96% match
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
£520.00
28 Jan 2026
96% match
The 2023-2028 Outlook for Myopia and Presbyopia Treatments in the United States
£520.00
10 Dec 2025
96% match
The 2023-2028 Outlook for Asthma Treatments in the United States
£520.00
22 Jan 2026
96% match
The 2023-2028 Outlook for Respiratory Disorder Treatments in the United States
£520.00
22 Jan 2026
96% match
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
£520.00
03 Feb 2026